“Seminal” study gene edits immune cells to target cancer
In a new study described as "seminal" and "pioneering", researchers in the US have successfully used CRISPR gene-editing technology to create personalized cancer-targeting immune cells, paving the way for future customized cancer treatments. Source of Article